How Singapore’s NCID Is Addressing Questions About SARS-CoV-2 | Asian Scientist Magazine

AsianScientist (May. 8, 2020) – Launched in September 2019, Singapore’s National Centre for Infectious Diseases (NCID) was designed to respond effectively to pandemics on a SARS-like scale.

With 330 beds and surge capacity to accommodate more than 500 patients should the need arise, the NCID is equipped with facilities such as negative pressure rooms and a high-level isolation unit. The newly established center was quickly put to the test when Singapore reported its first COVID-19 case on January 23, 2020.

Join our editor in chief Dr. Rebecca Tan as she speaks with three NCID clinicians on the frontlines of Singapore’s efforts to contain SARS-CoV-2. These clinicians are Dr. Shawn Vasoo, clinical director of NCID and head of the Infectious Disease Research Laboratory; senior consultant Dr. Kalisvar Marimuthu and consultant Dr. Sapna Sadarangani.

As clinical director of NCID, Vasoo coordinates research tackling different aspects of the virus, from serology to environmental impacts. Marimuthu has conducted a study on the persistence of SARS-CoV-2 on surfaces while Sadarangani is leading an effort to study exposure in Singapore’s healthcare workers through serology testing.

In the fourth webinar of our Wildtype Media Expert Opinion series, Singapore’s top clinicians leading the country’s COVID-19 response will provide insights from the frontlines and share their thoughts on coronavirus strategies moving forward.

Wednesday, May 13, 2020

10:00 am UK Time
5:00 pm Singapore/Hong Kong Time

Please register here.

Copyright: Asian Scientist Magazine.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Source link

Leave a Comment

Your email address will not be published.